Related Experiment Video
Updated: May 12, 2026

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
Published on: February 8, 2013
Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM
Rolf A Brekken1, Pauli Puolakkainen, David C Graves
1Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington 98104-2046, USA.
Abstract:
SPARC, a 32-kDa glycoprotein, participates in the regulation of morphogenesis and cellular differentiation through its modulation of cell-matrix interactions. Major functions defined for SPARC in vitro are de-adhesion and antiproliferation. In vivo, SPARC is restricted in its expression to remodeling tissues, including pathologies such as cancer. However, the function of endogenous SPARC in tumor growth and progression is not known. Here, we report that implanted tumors grew more rapidly in mice lacking SPARC. We observed that tumors grown in SPARC null mice showed alterations in the production and organization of ECM components and a decrease in the infiltration of macrophages. However, there was no change in the levels of angiogenic growth factors in comparison to tumors grown in wild-type mice, although there was a statistically significant difference in total vascular area. Whereas SPARC did inhibit the growth of tumor cells in vitro, it did not have a demonstrable effect on the proliferation or apoptosis of tumor cells in vivo. These data indicate that host-derived SPARC is important for the appropriate organization of the ECM in response to implanted tumors and highlight the importance of the ECM in regulating tumor growth.
Insights
Secreted acidic rich protein (SPARC) is crucial for regulating the tumor microenvironment. Mice lacking SPARC showed faster tumor growth, indicating SPARC
Area of Science:
- Biochemistry
- Oncology
- Extracellular Matrix Biology
Background:
- Secreted acidic rich protein (SPARC) is a glycoprotein involved in cell-matrix interactions, morphogenesis, and differentiation.
- SPARC exhibits de-adhesion and anti-proliferative functions in vitro and is expressed in remodeling tissues, including tumors.
- The role of endogenous SPARC in tumor progression remains largely unknown.
Purpose of the Study:
- To investigate the function of endogenous SPARC in tumor growth and progression using a mouse model.
- To determine the impact of SPARC deficiency on the tumor microenvironment, including extracellular matrix (ECM) organization and immune cell infiltration.
Main Methods:
- Implantation of tumors into SPARC-null and wild-type mice.
- Analysis of ECM component production and organization within tumors.
- Assessment of macrophage infiltration and angiogenic growth factor levels.
- Evaluation of tumor cell proliferation and apoptosis in vivo and in vitro.
Main Results:
- Tumors implanted in SPARC-null mice exhibited significantly accelerated growth compared to wild-type controls.
- SPARC deficiency led to altered ECM production and organization and reduced macrophage infiltration in tumors.
- No significant changes in angiogenic growth factor levels were observed, but total vascular area differed.
- SPARC inhibited tumor cell growth in vitro but showed no demonstrable effect on proliferation or apoptosis in vivo.
Conclusions:
- Host-derived SPARC plays a critical role in organizing the tumor microenvironment, particularly the ECM, in response to tumor implantation.
- The ECM, regulated by SPARC, is a key factor influencing tumor growth.
- These findings highlight SPARC's importance in modulating the tumor microenvironment and suggest potential therapeutic strategies targeting ECM remodeling.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

